Chemesis International Inc. (CSE:CSI) is a cannabis company expanding its presence across newly compliant dispensaries across California. Having established their presence in the Golden State, the company is looking to expand their operations in Latin America, where the medicinal cannabis industry is growing.
In an interview with James West from Midas Letter, Chemesis CEO Edgar Montero provided an overview of the company’s operations in California, where the company has deployed its California Sap brand and has also acquired Desert Zen, a fully compliant manufacturing and distribution company. Montero also gave viewers insight into the current regulations in the Californian market, which set strict parameters for the distribution and sale of cannabis products. As dispensaries come online with regulations launched in July 1, 2018, Chemesis is building relationships with more of these.
In his interview, Montero also addressed the company’s Latin American expansion plans. From his perspective, the Latin American market is anticipating further legalization and growth, akin to that which we have seen in Canada and the US. Seeing the potential for the size of the market, Chemesis is looking into building relationships with existing actors in the cannabis space.
“Remember that Latin America, it’s a market itself, and you need to build a relationship,” he said. “You need to do your due diligence very properly, because it’s a market that requires a very tight relationship, and this is what we’re working on right now.”
Moving forward, the company is also focused on building shareholder value. This is tied to the company’s recent $25 million equity financing agreement with Alumina Partners, which Montero believes is a key milestone for Chemesis.
To watch the full interview, click here.